| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Sound Technology Inc is a State College, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quality Progressions is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
National Committee for Quality Assurance is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Washington, DC. To find more information about National Committee for Quality Assurance, please visit www.ncqa.org
CareRev is a marketplace technology that connects hospitals and health systems and local, vetted healthcare professionals on demand. We help our customers build a more flexible and resilient workforce by lowering premium labor costs, automating staffing operations, and building a modern-day float pool powered by technology.